Cognitive impairment after the novel coronavirus COVID-19 in young people
https://doi.org/10.25789/YMJ.2023.82.17
Abstract
The aim of this study was to assess cognitive impairment in young people after a mild novel coronavirus infection (COVID-19).
The study participants during the acute phase of the disease complained of general weakness, headaches, mental exhaustion, muscle and joint pain, decreased attention, decreased sense of smell, sleep disturbance, apathy, shortness of breath and a feeling of pressure in the chest. All complaints regressed after recovery, and their frequency did not differ from those of complaints in the control group. Neuropsychological examination revealed a bit higher level of depression (10.5 vs. 6.5 points on the Beck scale), some decrease in visual memory (11 vs. 11.5 pictures) and higher incidence of general asthenia (74% vs. 44%) in COVID-19 patients. There was no correlation between the severity of cognitive impairment and the duration of COVID-19. Thus, COVID-19 is mildly accompanied by the development of mild cognitive impairment in young patients.
Supporting agencies: The work was carried out without financial support. The authors bear full responsibility for submitting the final version of the manuscript for publication. All authors participated in the development of the concept of the article and writing the manuscript. The final version of the manuscript was approved by all authors.
About the Authors
E. E. Konnikova
NEFU Medical Institute named after. M.K. Ammosov
Russian Federation
Russian Federation
Yakutsk
A. I. Borisov
NEFU Medical Institute named after. M.K. Ammosov
Russian Federation
Russian Federation
Yakutsk
A. A. Tappakhov
Medical Institute of NEFU named after M.K. Ammosov; Center for Neurodegenerative Diseases of the Yaroslavl Scientific Center of the Clinical Medical University
Russian Federation
Russian Federation
Yakutsk
T. Ya. Nikolaeva
NEFU Medical Institute named after. M.K. Ammosov
Russian Federation
Russian Federation
Yakutsk
References
1. Analysis of the epidemiological situation on COVID-19 / Popova T.E., Tikhonova O.G., Romanova A.N. [et al.] // Yakut Medical Journal. 2020. Vol. 3. P. 63-67. DOI: 10.25789/YMJ.2020.71.17.
2. Bazdyrev E.D. Coronavirus infection - an urgent problem of the 21<sup>st</sup> century // Complex problems of cardiovascular diseases. 2020. Vol. 9(2). P. 6-16. DOI: 10.17802/2306-1278-2020-9-2-6-16.
3. Cognitive impairment and neuropsychiatric consequences associated with COVID-19 / Kostenko E.V., Eneeva M.A., Petrova L.V. [et al] // Doctor.Ru. 2021. Vol. 20(5). P. 6-12. DOI: 10.31550/1727-2378-2021-20-5-6-12.
4. Ostroumova T.M., Chernousov P.A., Kuznetsov I.V. Cognitive impairment in patients with COVID-19 // Neurology, neuropsychiatry, psychosomatics. 2021. Vol. 13(1). P. 126–130. DOI: 10.14412/2074-2711-2021-1-126-130.
5. Pathogenetic mechanisms of neurological post-covid syndrome and the basis of its pathogenetic treatment and prevention / Vlasova T.I., Spirina M.A., Arsetyeva E.V. [et al]. // News of higher educational institutions. The Volga region. Medical Sciences. 2021. Vol. 4 (60). P. 129-142. DOI: 10.21685/2072-3032-2021-4-11.
6. The prevalence of cognitive and autonomic disorders of the nervous system among students who have had COVID-19 / Pelin A.I., Mukhametova N.N., Fakhrutdinova A.R. [et al] // Modern Science. 2022. Vol. 3(2). P. 232-236.
7. Cognitive disorders in young people after suffering from COVID-19 / Semenov V.A., Gruzdev D.O., Rechkin N.V. [et al.] // Universum: medicine and pharmacology. – 2022. – Vol. 1 (84). – P. 8-12.
8. Starchina Y.A., Vakhina N.V. Cognitive impairment after COVID-19 infection // Behavioral neurology. – 2021 – Vol. 1 – P. 18-27. DOI: 10.46393/2712-9675_2021_1_18-26.
9. Fedin A.I. Neurological complications of COVID-19 // Neuronews. 2021. Vol. 11 (85). P. 1-19.
10. Attributes and predictors of long Covid / Sudre C.H., Murray B., Varsavsky T. [et al.] // Nat Med. 2021. Vol. 27(4). P. 626-631. DOI: 10.1038/s41591-021-01292-y.
11. Clinical Characteristics of Coronavirus Disease 2019 in Chine. / Guan W.J., Ni Z.Y., Hu Y. [et al.] // N Engl J Med. 2020. Vol. 382(18). P. 1708-1720. DOI: 10.1056/NEJMoa2002032.
12. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study / Dennis A., Wamil M., Alberts J. [et al.] // BMJ Open. 2021. Vol. 11(3). e048391. DOI: 10.1136/bmjopen-2020-048391.
13. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections : a systematic review and meta-analysis with comparison to the COVID-19 pandemic / Rogers J.P., Chesney E., Oliver D. [et al.] // Lancet Psychiatry. 2020. Vol. 7(7). P. 611-627. DOI: 10.1016/S2215-0366(20)30203-0
14. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. / Huang C., Huang L., Wang Y. [et al.] // Lancet. 2021. Vol. 397(10270). P. 220-232. DOI: 10.1016/S0140-6736(20)32656-8.
Review
For citations:
Konnikova E.E., Borisov A.I., Tappakhov A.A., Nikolaeva T.Ya. Cognitive impairment after the novel coronavirus COVID-19 in young people. Yakut Medical Journal. 2023;(2):70-73. https://doi.org/10.25789/YMJ.2023.82.17
Views:
43
Email this article 